SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): October 23, 2002
AMERICAN BIO MEDICA CORPORATION
------------------------------------------------------
(Exact Name of Registrant as Specified in its Charter)
New York 0-28666 14-1702188
------------------------------ ------------------------ ----------------------
(State or Other (Commission File Number) (IRS Employer
Jurisdiction of Incorporation) Identification Number)
122 Smith Road, Kinderhook, NY 12106
---------------------------------------- ----------
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code: (800) 227-1243
ITEM 6. RESIGNATIONS OF REGISTRANT'S DIRECTORS
On October 23, 2002, the Board of Directors of the Registrant accepted
the resignation of Robert L. Aromando, Jr. from the Registrant's Board of
Directors. The Registrant is unaware of any disagreement Mr. Aromando has with
the Registrant on any matter relating to the Registrant's operations, policies
or practices, nor has Mr. Aromando provided a letter outlining any such
disagreements.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL STATEMENTS AND EXHIBITS.
(c) Exhibits.
The following exhibits are filed with this report on Form 8-K:
17.1 Letter of resignation from Robert L. Aromando, Jr.
dated October 21, 2002.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
AMERICAN BIO MEDICA CORPORATION (Registrant)
Dated: October 24, 2002
By: /s/ Keith E. Palmer
----------------------------------------
Keith E. Palmer
Chief Financial Officer
3
Exhibit Index
Exhibit No. Description Page No.
----------- ----------- --------
17.1 Letter of resignation from Robert L. 5
Aromando, Jr. dated October 21, 2002
4